Scherle Peggy
SEC CIK 1824632 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | CSO | 173.5K | — | $1.07M | 6 | 2021-07-27 | 2021-08-26 |
Most active insiders at PRLD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bonita David P | Dir, 10% | $12.50M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $12.50M | — |
| 3 | Huang Jane | Pres, CMO | — | — |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
Scherle Peggy made no open-market trades at PRLD in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-30 | 2021-08-26+ | PRLD | Prelude Therapeutics Inc | Scherle Peggy | CSO | S - Sale+OE | $35.75 | -7,714 | 173.5K | -4% | -$275.8K |
| DM | 2021-08-30 | 2021-08-26+ | PRLD | Prelude Therapeutics Inc | Scherle Peggy | CSO | M - OptEx | $1.43 | +7,714 | 178.9K | +5% | +$11.0K |
| DM | 2021-08-17 | 2021-08-13 | PRLD | Prelude Therapeutics Inc | Scherle Peggy | CSO | M - OptEx | $1.54 | +2,286 | 173.5K | +1% | +$3,526 |
| D | 2021-08-17 | 2021-08-13 | PRLD | Prelude Therapeutics Inc | Scherle Peggy | CSO | S - Sale+OE | $35.07 | -2,286 | 172.9K | -1% | -$80.2K |
| DM | 2021-07-29 | 2021-07-27 | PRLD | Prelude Therapeutics Inc | Scherle Peggy | CSO | S - Sale+OE | $35.47 | -20.0K | 172.9K | -10% | -$709.4K |
| D | 2021-07-29 | 2021-07-27 | PRLD | Prelude Therapeutics Inc | Scherle Peggy | CSO | M - OptEx | $1.43 | +20.0K | 192.9K | +12% | +$28.6K |
Purchase Sale Sale after option exercise All abbreviations